Vardenafil improves erectile function in men with diabetes
VARDENAFIL, a phosphodiesterase-5 inhibitor, improves
erectile dysfunction in men with type 1 and type 2 diabetes, according
to data from a phase III study. Data were presented last month at the
61st Annual American Diabetes Association Scientific Sessions.
The study involved 452 men aged 18 and older with
mildly to severely impaired erectile function who were randomised to receive
vardenafil 10mg or 20mg, or placebo on demand. Dr I. Goldstein, Boston
University Medical School, Massachusetts, and colleagues found that 72
per cent of participants in the 20mg group reported an improvement in
erectile dysfunction compared with 13 per cent in the placebo group. Participants
in the 10mg group showed a 57 per cent response rate.
Bayer plans to submit a licence application for
vardenafil for erectile dysfunction in the second half of 2001 and expects
to receive approval during the second half of 2002.
|
